vimarsana.com

Latest Breaking News On - Alexander lobo - Page 1 : vimarsana.com

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2024 Earnings Call Transcript

Operator: Greetings and welcome to Inhibikase Therapeutics First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Red-white
Alexander-lobo
Garth-lees-rolfe
Milton-werner
Inhibikase-therapeutics-inc
Nasdaq
National-institutes-of-health
National-institute-of-neurological-disease
Division-of-cardiology
Office-of-cardiology
National-cancer-institute
Inhibikase-therapeutics

Between The Lines at the New Diorama Theatre

Between The Lines at the New Diorama Theatre
londontheatre1.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from londontheatre1.com Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
Windrush
Gloucestershire
Tina-torbey
Vali-wright
Andrew-brown
Jack-baxter
Pauline-mcgrath
Alexander-lobo-moreno
Nassy-konan

Aileron Therapeutics, Inc.: Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split

BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients'

Boston
Massachusetts
United-states
Alexander-lobo
Liz-melone
Exchange-commission
Drug-administration
Computershare-trust-company-inc
Nasdaq
Nasdaq-capital-market
Computershare-trust-company
Private-securities-litigation-reform-act

Aileron Therapeutics (ALRN) Presents Strong Results from Phase 1 Study of ALRN-6924

Aileron Therapeutics (ALRN) Presents Strong Results from Phase 1 Study of ALRN-6924
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Manuel-aivado
Alexander-lobo
Allen-annis
Liz-melone
Exchange-commission
Research-at-aileron
Aileron-therapeutics-inc
International-conference-on-molecular
Drug-administration
Molecular-targets
Cancer-therapeutics
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.